Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Assets Average (2020 - 2025)

Biodesix (BDSX) has disclosed Assets Average for 6 consecutive years, with $88.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Assets Average fell 11.9% year-over-year to $88.1 million, compared with a TTM value of $88.1 million through Dec 2025, down 11.9%, and an annual FY2025 reading of $92.4 million, down 5.92% over the prior year.
  • Assets Average was $88.1 million for Q4 2025 at Biodesix, roughly flat from $88.2 million in the prior quarter.
  • Across five years, Assets Average topped out at $118.3 million in Q1 2021 and bottomed at $68.4 million in Q2 2022.
  • Average Assets Average over 5 years is $89.5 million, with a median of $88.2 million recorded in 2025.
  • The sharpest move saw Assets Average crashed 41.77% in 2022, then soared 32.95% in 2024.
  • Year by year, Assets Average stood at $83.0 million in 2021, then decreased by 6.01% to $78.1 million in 2022, then increased by 19.08% to $92.9 million in 2023, then rose by 7.59% to $100.0 million in 2024, then fell by 11.9% to $88.1 million in 2025.
  • Business Quant data shows Assets Average for BDSX at $88.1 million in Q4 2025, $88.2 million in Q3 2025, and $87.0 million in Q2 2025.